NewsCryptoaltFINS Partners with BitPath Holdings to Launch Gen 2 Digital Asset Treasury Strategy Powered by AI Analytics

altFINS Partners with BitPath Holdings to Launch Gen 2 Digital Asset Treasury Strategy Powered by AI Analytics

Author: ChainWire·

Key Takeaways

  • altFINS and BitPath Holdings announced a partnership to launch a Gen 2 Digital Asset Treasury strategy.
  • altFINS will provide crypto analytics, market intelligence, portfolio management infrastructure, and weekly performance reporting for BitPath.
  • Richard Fetyko, founder and CEO of altFINS, has been appointed to BitPath Holdings’ Advisory Board.
  • BitPath issued altFINS 2,561,822 restricted common shares, equal to 4.9% of its common shares outstanding.
  • The agreement gives BitPath the option to invest up to 2 million euros in altFINS for as much as a 22% ownership stake.
altFINS Partners with BitPath Holdings to Launch Gen 2 Digital Asset Treasury Strategy Powered by AI Analytics

Bratislava, Slovakia, August 28, 2026 (Chainwire) — altFINS j.s.a., a leading provider of proprietary crypto data analytics and AI-driven trading tools, has announced a strategic partnership with BitPath Holdings, Inc. aka Bio-Path Holdings, Inc. (OTC: BPTH) to launch a Gen 2 Digital Asset Treasury (“Gen 2 DAT”) strategy.

Under the partnership, altFINS will provide institutional-grade crypto analytics, market intelligence, and active portfolio management infrastructure to support BitPath Holdings’s corporate treasury pivot. Additionally, altFINS Founder and CEO Richard Fetyko has been appointed to BitPath Holdings’ Advisory Board to spearhead its digital asset strategy.

Redefining Corporate Treasury Management

The partnership marks a significant evolution from traditional “buy and hold” digital asset treasuries (Gen 1 DATs) toward an active, multi-asset management model. While early pioneers demonstrated that cryptocurrencies belong on corporate balance sheets, single-asset strategies frequently expose enterprises to severe concentration risk and market volatility. The Gen 1 template was popularized by MicroStrategy (since renamed Strategy), which began buying bitcoin for its balance sheet in August 2020 and has since been echoed by dozens of public companies, many of which funded purchases through equity and convertible debt offerings.

BitPath’s Gen 2 DAT is designed to outperform market cycles through active risk management—utilizing long and short positions and a diversified basket of projects at the intersection of blockchain and AI, including Layer 1 and Layer 2 networks, decentralized finance (DeFi), decentralized physical infrastructure networks (DePIN), and Real World Asset (RWA) tokenization.

To drive performance, altFINS will manage BitPath’s crypto exchange accounts and deliver weekly performance reports and strategic guidance. The strategy merges technical price trends with rigorous fundamental token metrics, adapting dynamically to market cycles and sentiment. That weekly reporting cadence will give observers a running view of how an actively managed corporate crypto portfolio behaves across market cycles—the central test of the Gen 2 thesis.

Strategic Alignment and Transaction Terms

The arrangement is structured to align the long-term growth and success of both organizations:

  • BitPath issued altFINS 2,561,822 restricted common shares, representing 4.9% of its common shares outstanding.
  • BitPath has the option to invest up to two million euros in altFINS for up to a 22% ownership stake.
  • altFINS will receive a 1.25% management fee on BitPath’s crypto portfolio, alongside performance bonuses tied to portfolio profits.

Richard Fetyko, Founder and CEO of altFINS, stated: “The era of passive ‘buy and hold’ digital asset treasuries is evolving. While early pioneers proved that cryptocurrencies belong on corporate balance sheets, a Gen 1 single-asset approach exposes companies to unnecessary concentration risk and market volatility. Through our partnership with BitPath Holdings, we are setting a new standard for Gen 2 treasury management—empowering corporate balance sheets with institutional-grade analytics, active risk management, and a diversified, data-driven multi-asset strategy.”

Vik Grover, CEO of BitPath Holdings, added: “Crypto markets are at an inflection point, driven by institutional adoption and a favorable regulatory environment in the U.S. and abroad. The scheduled September 15, 2026 Congressional Hearing on the Clarity Act and recently proposed SEC exemptions for crypto capital raises put the industry on the front burner for an explosive transformational period that will reboot our financial system using the blockchain. I believe the age of Gen 1 DATs will be eclipsed by active management and Gen 2 platforms using AI that marries technical analysis to fundamental research. I have high expectations for this Gen 2 DAT program and when combined with our crypto social network and token platform beta.mophoe.com, the value creation should be material.”

The Clarity Act cited by Grover—the Digital Asset Market Clarity Act—passed the U.S. House of Representatives in July 2025 and would divide regulatory jurisdiction over digital assets between the SEC and CFTC, while institutional access to the asset class has widened since U.S. spot bitcoin exchange-traded funds launched in January 2024.

About altFINS j.s.a.

altFINS j.s.a. is a cloud-based cryptocurrency market analysis and trading platform offering coin screening, interactive charting, automated chart pattern recognition, technical analysis, fundamental research, and on-chain data on a subscription basis. Platform features include:

  • Crypto Screener: Scans thousands of digital assets using over 150 technical indicators.
  • AI Chart Patterns: Automatically detects classic trading patterns such as triangles, wedges, and channels.
  • Trading Signals: Delivers AI-based trade setups complete with entry, exit, and stop-loss levels.
  • Data API: Supplies pre-computed analytics and metrics for developers and algorithmic traders.
  • Trading Indicators: Advanced tooling designed to streamline systematic strategy formulation.

More information is available at www.altfins.com.

About BitPath Holdings, Inc. aka Bio-Path Holdings, Inc. (OTC: BPTH)

BitPath Holdings, Inc. aka Bio-Path Holdings, Inc., is a biotechnology pioneer focused on mRNA-based treatments for rare diseases, including acute myeloid leukemia (AML). Its lead product candidate, prexigebersen (Liposomal Grb2 antisense), is a neutral-charge, liposome-incorporated antisense drug designed to inhibit the protein synthesis of Grb2, which has achieved favorable outcomes in initial sample populations. While exploring partnerships, licenses, and sales for its biotechnology pipeline, the Company is strategically pivoting to cryptocurrency trading and social media investments in the global market.

More information is available at www.biopathholdings.com.

Contact

Lenka Fetyko, altFINS — marketing@altfins.com

Source: Chainwire